Immune aging: two kinds of memory T cells and what they predict
Bottom line: Immune-aging blood signatures have Grade C evidence for associations with health and mortality, not for showing that supplements improve immune aging; the findings are observational, based on one-time measurements, and not an available clinical test.
A landmark 2026 single-cell map of human blood aging (Terekhova, Artyomov and colleagues, Immunity). The GZMK+ to GZMB+ effector-memory T-cell ratio, and a plasma-protein proxy for the GZMB+ side, tracked inflammation, self-reported health, all-cause death and metabolic and cardiovascular risk in large cohorts. It is observational, measured once, and not a clinical test you can order today. Grade C: strong description of how immune aging varies, not proof of cause or of any treatment.
Reviewed . We sell some of what we grade.

Editorial section. Research summaries are not product claims and contain no product links or offers. A summary is never proof that any product works.
- The question
- How does the immune system change with age, can a blood signature mark healthier versus less healthy trajectories, and does any of that mean a supplement can fix immune aging?
- Study design
- Terekhova et al. 2026 (Immunity, doi 10.1016/j.immuni.2026.09.012; Crossref and Europe PMC abstract checked, PMID 42854692): the authors combined seven public single-cell PBMC datasets with a new cohort, covering 2,609 mainly healthy adults of diverse ages, ancestries and sexes, and about 12.4 million blood immune cells, annotated into 59 cell types. They then built a plasma-protein signature for the CD8+ Tem GZMB+ state from proteomics in four cohorts and applied it in the UK Biobank. A WashU Medicine summary of the paper states that the protein model was applied to about 50,000 UK Biobank participants with up to about 15 years of health records (UK Biobank application 88907). Funders listed by WashU include the Aging Biology Foundation, NIH grants UH2 AG056925 and U01 AI165452, and others. [1][2][3]
- What they found
- Age remodeled many immune cell types, with conserved and cohort-specific patterns, plus sex and ancestry differences. CD8+ T cells drove much of the person-to-person spread. As naive T cells and recent thymic emigrants fell with age, effector-memory CD8+ cells branched toward granzyme K (GZMK+) or granzyme B (GZMB+) states. A higher GZMK+ to GZMB+ ratio marked healthier aging trajectories; a GZMB+-leaning profile tracked chronic viral exposure (including CMV) and disease-linked immune dysregulation, with the dominant driver varying by population. The Tem GZMB+ plasma-protein signature associated with inflammaging, poorer self-reported health, all-cause mortality, and higher risk of immune-related, metabolic and cardiovascular disease. WashU's summary adds higher later rates of type 2 diabetes, hypertension, liver disease and kidney failure in the GZMB+-leaning group. The abstract does not report a clear link from this signature to neurodegenerative disease. [1][2][3]
- Limitations
- This is association, not cause: a single blood draw does not prove that shifting the ratio would change risk. Counts were modeled from plasma proteins in UK Biobank because direct CD8+ Tem counts were not available there. The window is blood, not tissue. Ancestry coverage still leaves uncertainty for some groups. GZMK+ cells are not simply 'good'; they can also promote inflammation in other settings. No clinical blood test from this work is routinely available yet; the authors are working toward one. We did not have full-text access (subscription); numbers above come from the abstract, Crossref metadata and the WashU Medicine news summary of the paper.
- What this does not mean
- Nothing here shows that zinc, NAC, vitamin D or any other supplement treats, reverses or measures immune aging. Our immunity hub grades those ingredients for colds and related uses, which is a different question. We do not sell an immune-aging test or an immune-aging product. This page is education on how immune aging is being mapped in research. The FDA has not evaluated these statements; they are not medical advice. If you are pregnant, on medication or have a condition, check with a doctor. Lifestyle, vaccines and clinical care still come first for immune health.
- Sources
- Terekhova M et al. Immunity. 2026. Single-cell analyses of global cohorts; GZMK+/GZMB+ Tem ratio and plasma signature. PMID 42854692. doi.org/10.1016/j.immuni.2026.09.012
- WashU Medicine news summary of Terekhova 2026 (9 Oct 2026): methods outline, ~50,000 UK Biobank application, funders. medicine.washu.edu/news/immune-cell-map-uncovers-how-individual-aging-trajectories-diverge/
- Terekhova M, Bohacova P, Artyomov MN. Immunity. 2025;58(11):2646-2669. Human immune aging review (prior lab context). doi.org/10.1016/j.immuni.2025.10.009
Related summaries
Spot an error? Email hello@everstackhealth.com and we will correct it within 48 hours.